Marc Sabé Richer
Director/Board Member at MICRON INVERSIONES, SICAV, S.A.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Raúl Insa Boronat | M | - |
SOM Innovation Biotech SA
 SOM Innovation Biotech SA Pharmaceuticals: MajorHealth Technology SOM Innovation Biotech SA engages in the discovery and development of new indications for known drugs. Its pipeline consists of repositioned compounds for the treatment of amyloidosis, huntington's disease, hyperplasia, glioblastoma, and alzheimer's disease. The company was founded by Raul Insa Boronat and Ignasi Belda Reig on December 30, 2009 and is headquartered in Barcelona, Spain. | 15 years |
| Juan Sabé Solé | M | - |
Factotum Trading SICAV SA
 Factotum Trading SICAV SA Investment Trusts/Mutual FundsMiscellaneous Factotum Trading SICAV SA invests directly or indirectly in fixed-income securities, equity assets, stocks, and hedge funds. The company was founded on August 9, 2000 and is headquartered in Madrid, Spain. | - |
| Jaume Puig Ribera | M | - |
Factotum Trading SICAV SA
Factotum Trading SICAV SA Investment Trusts/Mutual FundsMiscellaneous Factotum Trading SICAV SA invests directly or indirectly in fixed-income securities, equity assets, stocks, and hedge funds. The company was founded on August 9, 2000 and is headquartered in Madrid, Spain. | 16 years |
| Pere Sitjà Miquel | M | - |
Factotum Trading SICAV SA
Factotum Trading SICAV SA Investment Trusts/Mutual FundsMiscellaneous Factotum Trading SICAV SA invests directly or indirectly in fixed-income securities, equity assets, stocks, and hedge funds. The company was founded on August 9, 2000 and is headquartered in Madrid, Spain. | 16 years |
| Joan Renart Montalat | F | - | - | |
| Joaquim Hortala Vallve | M | - |
Factotum Trading SICAV SA
Factotum Trading SICAV SA Investment Trusts/Mutual FundsMiscellaneous Factotum Trading SICAV SA invests directly or indirectly in fixed-income securities, equity assets, stocks, and hedge funds. The company was founded on August 9, 2000 and is headquartered in Madrid, Spain. | 16 years |
| Oscar Huertas | M | - |
SOM Innovation Biotech SA
SOM Innovation Biotech SA Pharmaceuticals: MajorHealth Technology SOM Innovation Biotech SA engages in the discovery and development of new indications for known drugs. Its pipeline consists of repositioned compounds for the treatment of amyloidosis, huntington's disease, hyperplasia, glioblastoma, and alzheimer's disease. The company was founded by Raul Insa Boronat and Ignasi Belda Reig on December 30, 2009 and is headquartered in Barcelona, Spain. | 12 years |
| Martí Dalmases | M | - |
SOM Innovation Biotech SA
SOM Innovation Biotech SA Pharmaceuticals: MajorHealth Technology SOM Innovation Biotech SA engages in the discovery and development of new indications for known drugs. Its pipeline consists of repositioned compounds for the treatment of amyloidosis, huntington's disease, hyperplasia, glioblastoma, and alzheimer's disease. The company was founded by Raul Insa Boronat and Ignasi Belda Reig on December 30, 2009 and is headquartered in Barcelona, Spain. | - |
| Núria Reig | M | - |
SOM Innovation Biotech SA
SOM Innovation Biotech SA Pharmaceuticals: MajorHealth Technology SOM Innovation Biotech SA engages in the discovery and development of new indications for known drugs. Its pipeline consists of repositioned compounds for the treatment of amyloidosis, huntington's disease, hyperplasia, glioblastoma, and alzheimer's disease. The company was founded by Raul Insa Boronat and Ignasi Belda Reig on December 30, 2009 and is headquartered in Barcelona, Spain. | - |
| Jordi Sabé Richer | M | - | - | |
| Guillermo Fajardo Gerez | M | - | - | |
| Alberto Stampa Diez del Corral | M | - |
SOM Innovation Biotech SA
SOM Innovation Biotech SA Pharmaceuticals: MajorHealth Technology SOM Innovation Biotech SA engages in the discovery and development of new indications for known drugs. Its pipeline consists of repositioned compounds for the treatment of amyloidosis, huntington's disease, hyperplasia, glioblastoma, and alzheimer's disease. The company was founded by Raul Insa Boronat and Ignasi Belda Reig on December 30, 2009 and is headquartered in Barcelona, Spain. | - |
| Antoni Salgado | M | - |
SOM Innovation Biotech SA
SOM Innovation Biotech SA Pharmaceuticals: MajorHealth Technology SOM Innovation Biotech SA engages in the discovery and development of new indications for known drugs. Its pipeline consists of repositioned compounds for the treatment of amyloidosis, huntington's disease, hyperplasia, glioblastoma, and alzheimer's disease. The company was founded by Raul Insa Boronat and Ignasi Belda Reig on December 30, 2009 and is headquartered in Barcelona, Spain. | - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| Spain | 13 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Marc Sabé Richer
- Personal Network
